Christi Waarich | Director of Investor Relations and Corporate Communications |
Robert Gould | President and Chief Executive Officer |
Owen Wallace | Chief Scientific Officer |
Bryan Stuart | Chief Operating Officer |
Diego Cadavid | Senior Vice President of Clinical Development |
Matthew Harrison | Morgan Stanley |
Joseph Schwartz | SVB Leerink |
Tazeen Ahmad | Bank of America |
Good morning and welcome to the Fulcrum Therapeutics Fourth Quarter and Full Year 2019 Conference Call. Currently, all participants are in listen-only mode. There will be a question-and-answer session at the end of this call.
I would now like to turn the call over to Christi Waarich, Director of Investor Relations and Corporate Communications of Fulcrum. Please proceed.